2023 Global Oncology Summit: Focus on Sustainability

Bellevue, WA US
October 28, 2023

This CME-accredited activity, “2023 Global Oncology Summit: Focus on Sustainability”, is a half-day hybrid conference featuring didactics, panel discussions, and abstract presentations. The expert faculty will provide a comprehensive overview of the sustainable approach to establishing global oncology programs in low and middle-income countries (LMIC). They will discuss the challenges and evidence-based solutions to tackle these issues. 

Target Audience

  • Physicians 
  • Nurse Practitioners/ Physician Assistants
  • Nurses
  • Pharmacists
  • Others interested in Global Oncology

Organizing Committee

Conference Director:

Binay Shah, MD, MHA - Binaytara Foundation

Conference Chair:

Jerry Radich, MD - Fred Hutchinson Cancer Center

Learning Objectives

Upon successful completion of this educational activity, participants will be able to: 

  • Describe the current state of access to cancer care in LMIC
  • Review Challenges to access to cancer care in LMIC
  • Incorporate evidence-based strategies to establish successful global oncology programs
  • Describe successful models to create sustainable global oncology programs
Course summary
Available credit: 
  • 3.50 AMA PRA Category 1 Credit™
    The Binaytara Foundation is accredited by the Washington State Medical Association to provide continuing medical education for physicians. The Binaytara Foundation designates this live activity for a maximum of 3.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity meets the criteria for up to 3.50 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.
  • 3.50 Nursing Contact Hours
    Provider approved by the California Board of Registered Nursing, Provider # CEP17035, for 3.50 Contact Hours.
Course opens: 
08/30/2023
Course expires: 
01/09/2024
Event starts: 
10/28/2023 - 8:00am PDT
Event ends: 
10/28/2023 - 1:05pm PDT
Cost:
$0.00
Add to calendar: 

OCTOBER 28, 2023

All times are listed in Pacific Time (PT)

08:00 AM - 08:15 AM  Opening Remarks: State of Cancer Care in LMIC - Challenges and Opportunities - Jerry Radich, MD

08:15 AM - 09:00 AM  Session I: Infrastructure Development

Moderator: Andrea Wahner Hendrickson, MD

08:15 AM - 08:30 AM  Keynote Speech - Binay Shah, MD, MHA

08:30 AM - 09:00 AM  Panel Discussion

09:00 AM - 09:45 AM  Session II: Successful Partnerships

Moderator: Jerry Radich, MD

09:00 AM - 09:15 AM  Approach to Successful Partnership With Local Stakeholders - Dinesh Pendharkar, MD, PhD, FASCO

09:15 AM - 09:30 AM  Tumor Board - Binaytara Foundation's Experience - Joseph Rosales, MD

09:30 AM - 09:45 AM  Panel Discussion - Sarah Kutika Nyagabona, MD, MMed; Barry Pizer, MBChB, PhD, FRCPCH

09:45 AM - 10:00 AM  BREAK

10:00 AM - 11:00 AM  Session III: Establishment of Diagnostic Departments

Moderator: Dan Milner, MD, MSc

10:00 AM - 10:10 AM  Establishment of Radiology - Saurabh Jha, MBBS, MRCS, MS

10:10 AM - 10:20 AM  Establishment of Laboratory/Pathology - Steve Kussick, MD, PhD

10:20 AM - 10:30 AM  Research Infrastructure - Edus Houston Warren, MD, PhD

10:30 AM - 11:00 AM  Panel Discussion

11:00 AM - 12:00 PM  Session IV: Sustainability

Moderator: Manisha Bhattacharya, MD, MBA

11:00 AM - 11:15 AM  Access to Drugs and Technology - Pat Garcia-Gonzalez, MS

11:15 AM - 11:30 AM  Sustainability of Global Oncology Programs: Successful Models - Shailesh Shrikhande, MD, MS, FRCS

11:30 AM - 12:00 PM  Panel Discussion - Ben Li, MD, MBA; Darya Kizub, MD

12:00 PM - 12:05 PM  Adjourn

Binaytara Foundation
3380 146th Place SE
Suite 330
Bellevue, WA 98007
United States

IDENTIFICATION AND MITIGATION OF POTENTIAL CONFLICT OF INTERESTS:

All conflict of interest has been identified and mitigated for individuals in control of contents.

PLANNING COMMITTEE DISCLOSURE STATEMENT:

None of the members of the planning committee, nor any member of their immediate families, have a relevant financial interest in or affiliation with any commercial supporter of this educational activity and/or with the manufacturer(s) of commercial products and/or providers of any commercial services discussed in this educational activity.

Course Director(s)

Jerald Radich, MD

has a financial relationship (Other) with Cepheid;.
has a financial relationship (Other) with NuProbe;.
has a financial relationship (Other) with Novartis;.
Speaker/Topic Presenter(s)

Pat Garcia-Gonzalez, MS

has a financial relationship (Other) with Pfizer;.

SAURABH JHA, MBBS MRCS MS

has no relevant financial relationships to disclose at this time.

Darya Kizub, MD

has no relevant financial relationships to disclose at this time.

Steven Kussick, MD, PhD

has no relevant financial relationships to disclose at this time.

Benjamin Li, MD, MBA

has no relevant financial relationships to disclose at this time.

Sarah Nyagabona, Clinical Oncologist MD, Mmed

has no relevant financial relationships to disclose at this time.

Dinesh Pendharkar, Director Sarvodaya Cancer Institute, MD Phd FASCO

has no relevant financial relationships to disclose at this time.

Barry Pizer

has no relevant financial relationships to disclose at this time.

Joseph Rosales, MD

has no relevant financial relationships to disclose at this time.

Shailesh Shrikhande

has no relevant financial relationships to disclose at this time.

Edus Warren, MD, PhD

has no relevant financial relationships to disclose at this time.
Moderator(s)

Manisha Bhattacharya

has no relevant financial relationships to disclose at this time.

Danny Milner, Jr, MD, MSc, MBA

has no relevant financial relationships to disclose at this time.

Andrea Wahner Hendrickson, M.D

has a financial relationship (Other) with TORL biotherapeutics;.
has a financial relationship (Other) with Prolynx;.
has a financial relationship (Other) with Oxcia;.
Planning committee(s)

Binay Shah, MD, MHA

has no relevant financial relationships to disclose at this time.

Available Credit

  • 3.50 AMA PRA Category 1 Credit™
    The Binaytara Foundation is accredited by the Washington State Medical Association to provide continuing medical education for physicians. The Binaytara Foundation designates this live activity for a maximum of 3.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity meets the criteria for up to 3.50 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.
  • 3.50 Nursing Contact Hours
    Provider approved by the California Board of Registered Nursing, Provider # CEP17035, for 3.50 Contact Hours.

 

 

Price

Cost:
$0.00
Please login or register to take this course.

 

CANCELLATION POLICY

You may cancel your enrollment at any time. Cancellation fees apply as below:

  • 50% of the paid registration fee will be refunded if registration is canceled six weeks before the conference.
  • No refunds will be issued if registration is canceled after that date.  

No credits will be offered if you do not complete all required steps of this activity, including registration and participation in the live meeting.